dedicated to the research and development of Nitric oxide
Nitric Oxide Services, LLC is dedicated to the research and development of Nitric Oxide (NO). Our highly qualified team of scientists have decades of experience in the chemistry and biology of nitric oxide. Our clients have included the National Cancer Institute (NCI), major medical institutions, universities, Fortune 500 companies, and biotech start-ups.
Our secured-access laboratory with a customized nitric oxide delivery platform and analytical instrumentation is housed on the campus of Walsh University in the St. John Paul II Center for Science Innovation which has access to state of the art analytical equipment, tissue culture, and chemical reactors.
Nitric Oxide Services has access to proprietary nitric oxide-donor compounds, synthesis facilities and analytical methods and instrumentation which provides a comprehensive platform to meet the challenge of any NO-based research project from inception to completion. To learn more about our capabilities, click below:
IN THE NEWS
(click on the text to access article)
Sysel AM, Dunphy MJ, Bauer JA. Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study. J Antibiotics. 2020 Dec 28:1–6. doi: 10.1038/s41429-020-00397-9. Epub ahead of print. PMID: 33361779; PMCID: PMC7767638.
Bauer JA, Lupica JA, Didonato JA, Lindner DJ. Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance. Anticancer Res. 2020 Dec;40(12):6751-6763. doi: 10.21873/anticanres.14698. Epub 2020 Dec 7. PMID: 33288568.
Sysel AM, Dunphy MJ, Lindner DJ, DiDonato JA, Lupica JA, Bauer JA. Comment on the importance of using nitric oxide gas in the synthesis of nitrosylcobalamin and ICH-validated methods to assess purity and stability. J Biol Chem. 2020 Oct 23;295(43):14789. doi: 10.1074/jbc.L120.016007. PMID: 33097647; PMCID: PMC7586211.